We need regulatory reform to mine and process critical minerals at home.
Healthcare is a right for everyone, and access to prescription medication should not be reserved as a privilege only for the wealthy few.
Policies like referencing pricing and government price-settings will effectively turn our biopharma industry to a risk-averse, think-inside-...
We need a robust biopharma industry, and I think everyone agrees to that, investing in rare diseases.
I want to respond to my good friend, Representative Castor, with regard--she brought up the VA.
The status quo is not acceptable. Congress must act to ensure that the American people have access to and can afford the treatments that the...
If I could, I want to ask a last question to Dr. Gupta because the United States, we are still--across the country still experiencing a wave...
So we know the loser here is going to be the American public if we don't get a bill to the President's desk for signature.
But pursuing this highly partisan H.R. 3 is just an example of overreach, unfortunate overreach, that occurs too often in Washington, and it...
H.R. 3, unfortunately, is an overreach, and unfortunately it gives me the impression, for those in the package, that Congress is seemingly w...
What's the difference between $7.25 an hour and zero?
This Congress can and should be the Congress that finally takes a step in that direction.
Not enough people can afford barbecue.
We pay a lot of respect to these people.
Are you willing to work with us, or--to make these reforms?
I want to see in your budget, do you have enough money in there for research to be able to get us down to 80 percent by 2030?
They are retiring them because of the regulatory uncertainty, and the threats that are being posed to them.
We have to start now, because it takes 7 to 8 years to do this.
